Characterization of novel neutralizing mouse monoclonal antibody JM1-24-3 developed against MUC18 in metastatic melanoma.
Feng R, Wang Y, Ramachandran V, Ma Q, May MM, Li M, Zhou JX, Xu X, Xu K, Fang S, Xia W, Sui D, Liu H, Gao X, Prieto V, Blacklow SC, Lu M, Lee JE.
Feng R, et al. Among authors: zhou jx.
J Exp Clin Cancer Res. 2020 Dec 5;39(1):273. doi: 10.1186/s13046-020-01722-8.
J Exp Clin Cancer Res. 2020.
PMID: 33278894
Free PMC article.